BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 27279483)

  • 1. Gene set enrichment analysis and ingenuity pathway analysis of metastatic clear cell renal cell carcinoma cell line.
    Khan MI; Dębski KJ; Dabrowski M; Czarnecka AM; Szczylik C
    Am J Physiol Renal Physiol; 2016 Aug; 311(2):F424-36. PubMed ID: 27279483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Gene Expression Profiling of Primary and Metastatic Renal Cell Carcinoma Stem Cell-Like Cancer Cells.
    Khan MI; Czarnecka AM; Lewicki S; Helbrecht I; Brodaczewska K; Koch I; Zdanowski R; Król M; Szczylik C
    PLoS One; 2016; 11(11):e0165718. PubMed ID: 27812180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene expression analysis in clear cell renal cell carcinoma using gene set enrichment analysis for biostatistical management.
    Maruschke M; Reuter D; Koczan D; Hakenberg OW; Thiesen HJ
    BJU Int; 2011 Jul; 108(2 Pt 2):E29-35. PubMed ID: 21435154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microarray gene expression profiling and analysis in renal cell carcinoma.
    Liou LS; Shi T; Duan ZH; Sadhukhan P; Der SD; Novick AA; Hissong J; Skacel M; Almasan A; DiDonato JA
    BMC Urol; 2004 Jun; 4():9. PubMed ID: 15212686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
    Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
    J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of genes and pathways involved in kidney renal clear cell carcinoma.
    Yang W; Yoshigoe K; Qin X; Liu JS; Yang JY; Niemierko A; Deng Y; Liu Y; Dunker A; Chen Z; Wang L; Xu D; Arabnia HR; Tong W; Yang M
    BMC Bioinformatics; 2014; 15 Suppl 17(Suppl 17):S2. PubMed ID: 25559354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinase Gene Expression Profiling of Metastatic Clear Cell Renal Cell Carcinoma Tissue Identifies Potential New Therapeutic Targets.
    Ghatalia P; Yang ES; Lasseigne BN; Ramaker RC; Cooper SJ; Chen D; Sudarshan S; Wei S; Guru AS; Zhao A; Cooper T; Della Manna DL; Naik G; Myers RM; Sonpavde G
    PLoS One; 2016; 11(8):e0160924. PubMed ID: 27574806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptomic data from two primary cell models stimulating human monocytes suggest inhibition of oxidative phosphorylation and mitochondrial function by N. meningitidis which is partially up-regulated by IL-10.
    Gopinathan U; Øvstebø R; Brusletto BS; Olstad OK; Kierulf P; Brandtzaeg P; Berg JP
    BMC Immunol; 2017 Oct; 18(1):46. PubMed ID: 29078758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tpl2 kinase impacts tumor growth and metastasis of clear cell renal cell carcinoma.
    Lee HW; Joo KM; Lim JE; Cho HJ; Cho HJ; Park MC; Seol HJ; Seo SI; Lee JI; Kim S; Jeong BC; Nam DH
    Mol Cancer Res; 2013 Nov; 11(11):1375-86. PubMed ID: 23982215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data.
    Lenburg ME; Liou LS; Gerry NP; Frampton GM; Cohen HT; Christman MF
    BMC Cancer; 2003 Nov; 3():31. PubMed ID: 14641932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and prognostic significance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma.
    Chen D; Gassenmaier M; Maruschke M; Riesenberg R; Pohla H; Stief CG; Zimmermann W; Buchner A
    J Urol; 2014 Feb; 191(2):479-86. PubMed ID: 24012533
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs with prognostic potential for metastasis in clear cell renal cell carcinoma: a comparison of primary tumors and distant metastases.
    Heinzelmann J; Unrein A; Wickmann U; Baumgart S; Stapf M; Szendroi A; Grimm MO; Gajda MR; Wunderlich H; Junker K
    Ann Surg Oncol; 2014 Mar; 21(3):1046-54. PubMed ID: 24242678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression profiling of human renal carcinomas with functional taxonomic analysis.
    Gieseg MA; Cody T; Man MZ; Madore SJ; Rubin MA; Kaldjian EP
    BMC Bioinformatics; 2002 Sep; 3():26. PubMed ID: 12356337
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analysis of renal carcinoma: adipose differentiation-related protein as a potential diagnostic and prognostic biomarker for clear-cell renal carcinoma.
    Yao M; Tabuchi H; Nagashima Y; Baba M; Nakaigawa N; Ishiguro H; Hamada K; Inayama Y; Kishida T; Hattori K; Yamada-Okabe H; Kubota Y
    J Pathol; 2005 Feb; 205(3):377-87. PubMed ID: 15682440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global analysis of metastasis-associated gene expression in primary cultures from clinical specimens of clear-cell renal-cell carcinoma.
    Tan X; Zhai Y; Chang W; Hou J; He S; Lin L; Yu Y; Xu D; Xiao J; Ma L; Wang G; Cao T; Cao G
    Int J Cancer; 2008 Sep; 123(5):1080-8. PubMed ID: 18546293
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene signatures of progression and metastasis in renal cell cancer.
    Jones J; Otu H; Spentzos D; Kolia S; Inan M; Beecken WD; Fellbaum C; Gu X; Joseph M; Pantuck AJ; Jonas D; Libermann TA
    Clin Cancer Res; 2005 Aug; 11(16):5730-9. PubMed ID: 16115910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarker identification in clear cell renal cell carcinoma based on miRNA-seq and digital gene expression-seq data.
    Guan L; Tan J; Li H; Jin X
    Gene; 2018 Mar; 647():205-212. PubMed ID: 29253611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The L1 cell adhesion molecule is induced in renal cancer cells and correlates with metastasis in clear cell carcinomas.
    Allory Y; Matsuoka Y; Bazille C; Christensen EI; Ronco P; Debiec H
    Clin Cancer Res; 2005 Feb; 11(3):1190-7. PubMed ID: 15709188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor suppressor activity and epigenetic inactivation of hepatocyte growth factor activator inhibitor type 2/SPINT2 in papillary and clear cell renal cell carcinoma.
    Morris MR; Gentle D; Abdulrahman M; Maina EN; Gupta K; Banks RE; Wiesener MS; Kishida T; Yao M; Teh B; Latif F; Maher ER
    Cancer Res; 2005 Jun; 65(11):4598-606. PubMed ID: 15930277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.